Literature DB >> 31295561

IgE deficiency is associated with high rates of new malignancies: Results of a longitudinal cohort study.

Denisa Ferastraoaru1, David Rosenstreich2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31295561     DOI: 10.1016/j.jaip.2019.06.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Antibodies as biomarkers for cancer risk: a systematic review.

Authors:  Maria J Monroy-Iglesias; Silvia Crescioli; Kerri Beckmann; Nga Le; Sophia N Karagiannis; Mieke Van Hemelrijck; Aida Santaolalla
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

Review 2.  AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI).

Authors:  D Ferastraoaru; H J Bax; C Bergmann; M Capron; M Castells; D Dombrowicz; E Fiebiger; H J Gould; K Hartmann; U Jappe; G Jordakieva; D H Josephs; F Levi-Schaffer; V Mahler; A Poli; D Rosenstreich; F Roth-Walter; M Shamji; E H Steveling-Klein; M C Turner; E Untersmayr; S N Karagiannis; E Jensen-Jarolim
Journal:  Clin Transl Allergy       Date:  2020-07-17       Impact factor: 5.871

3.  IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype.

Authors:  Mano Nakamura; Elmira Amiri Souri; Gabriel Osborn; Roman Laddach; Jitesh Chauhan; Chara Stavraka; Sara Lombardi; Anna Black; Atousa Khiabany; Duaa O Khair; Mariangela Figini; Anna Winship; Sharmistha Ghosh; Ana Montes; James F Spicer; Heather J Bax; Debra H Josephs; Katie E Lacy; Sophia Tsoka; Sophia N Karagiannis
Journal:  Cancers (Basel)       Date:  2020-11-15       Impact factor: 6.639

Review 4.  IgE Antibodies against Cancer: Efficacy and Safety.

Authors:  Jitesh Chauhan; Alex J McCraw; Mano Nakamura; Gabriel Osborn; Heng Sheng Sow; Vivienne F Cox; Chara Stavraka; Debra H Josephs; James F Spicer; Sophia N Karagiannis; Heather J Bax
Journal:  Antibodies (Basel)       Date:  2020-10-16

Review 5.  Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments.

Authors:  Alex J McCraw; Jitesh Chauhan; Heather J Bax; Chara Stavraka; Gabriel Osborn; Melanie Grandits; Jacobo López-Abente; Debra H Josephs; James Spicer; Gerd K Wagner; Sophia N Karagiannis; Alicia Chenoweth; Silvia Crescioli
Journal:  Cancers (Basel)       Date:  2021-09-04       Impact factor: 6.575

6.  Is There a Clinical Significance of Very Low Serum Immunoglobulin E Level?

Authors:  Serdar Al; Suna Asilsoy; Nevin Uzuner; Gizem Atakul; Özge Atay; Özge Kangallı; Işık Odaman Al; Özkan Karaman
Journal:  J Clin Immunol       Date:  2021-09-03       Impact factor: 8.317

Review 7.  The other side of the coin: IgE deficiency, a susceptibility factor for malignancy occurrence.

Authors:  Denisa Ferastraoaru; Galateja Jordakieva; Erika Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2021-02-06       Impact factor: 4.084

Review 8.  Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer.

Authors:  Mohammad Fereydouni; Mona Motaghed; Elnaz Ahani; Tal Kafri; Kristen Dellinger; Dean D Metcalfe; Christopher L Kepley
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

Review 9.  Isotype selection for antibody-based cancer therapy.

Authors:  N Vukovic; A van Elsas; J S Verbeek; D M W Zaiss
Journal:  Clin Exp Immunol       Date:  2020-11-30       Impact factor: 5.732

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.